Chemotherapy & Breast Cancer: Why It Doesn’t Work for Some
- New research highlights the connection between common lifestyle diseases and more aggressive forms of breast cancer, emphasizing the need for tailored treatment plans.
- Breast cancer remains the most prevalent cancer among women globally. The world Health Organization (WHO) estimates that in 2024, approximately 2.4 million women worldwide received a breast cancer...
- Mandeep Singh Malhotra, Director of Surgical Oncology at CK Birla Hospital, Delhi, explains that underlying health conditions can significantly impact cancer progression and treatment efficacy.
“`html
Lifestyle Disease Link to Aggressive Breast Cancer & the Rise of Personalized Treatment
Table of Contents
New research highlights the connection between common lifestyle diseases and more aggressive forms of breast cancer, emphasizing the need for tailored treatment plans.
The Global Breast Cancer Landscape
Breast cancer remains the most prevalent cancer among women globally. The world Health Organization (WHO) estimates that in 2024, approximately 2.4 million women worldwide received a breast cancer diagnosis,resulting in around 685,000 deaths. Despite advancements in treatment, a critically important challenge remains: variable patient responses to chemotherapy.
The Link Between Lifestyle Diseases and Aggressive Cancer
Dr. Mandeep Singh Malhotra, Director of Surgical Oncology at CK Birla Hospital, Delhi, explains that underlying health conditions can significantly impact cancer progression and treatment efficacy. “Conditions like diabetes, obesity, and cardiovascular disease can create an inflammatory environment within the body. This,properly,can lead to fibrosis and inflammation,making tumors harder to treat,” he explains. Fibrosis, the thickening and scarring of tissue, can impede drug delivery and reduce the effectiveness of chemotherapy.
Inflammation, a natural immune response, can be hijacked by cancer cells to promote their growth and spread. Chronic inflammation is increasingly recognized as a key driver of cancer advancement and resistance to therapy. Research published in the journal Cancers details the complex interplay between inflammation, the tumor microenvironment, and treatment outcomes.
Why chemotherapy Responses Vary & the Need for Personalization
The variability in chemotherapy responses underscores the importance of personalized treatment plans. “By understanding tumour biology, genetics, and patient-specific factors, doctors can tailor therapies to achieve better results,” says Dr. Malhotra. This approach moves away from a “one-size-fits-all” model and towards treatments designed for the individual characteristics of both the patient and their cancer.
Personalized medicine utilizes several tools, including:
- Genomic Sequencing: Identifying specific genetic mutations driving cancer growth.
- Biomarker Analysis: measuring proteins or other molecules that indicate cancer presence and response to treatment.
- Lifestyle & Comorbidity Assessment: Evaluating the impact of existing health conditions on treatment efficacy.
The Future of Breast Cancer Treatment
The future of breast cancer treatment lies in a more holistic and individualized approach. This includes not only advanced therapies but also a focus on preventative measures and managing underlying health conditions. Early detection through regular screenings, coupled with lifestyle modifications to reduce risk factors, remains crucial.